Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Cutaneous t-cell lymphoma stage iv: Which Medications Are Safest? (36 Drugs Compared)

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

36 medications are used for Cutaneous t-cell lymphoma stage iv, with 132 combined adverse event reports. The most reported drugs for Cutaneous t-cell lymphoma stage iv are MOGAMULIZUMAB-KPKC and MOGAMULIZUMAB.

132
Total Reports
36
Drugs Used

All Medications for Cutaneous t-cell lymphoma stage iv Ranked by Safety Reports

Drug Brand Reports Deaths (all) Hosp. (all) Death Rate
MOGAMULIZUMAB-KPKC - 58 161 198 13.6%
MOGAMULIZUMAB POTELIGEO 11 128 181 29.0%
BEXAROTENE Bexarotene 9 134 177 17.7%
METHOTREXATE Methotrexate 9 21,265 68,793 8.4%
GEMCITABINE Gemcitabine 8 5,142 12,268 16.4%
BRENTUXIMAB VEDOTIN ADCETRIS 7 1,922 3,781 19.8%
CYCLOPHOSPHAMIDE Cyclophosphamide 7 25,330 45,054 19.7%
DOXORUBICIN Doxorubicin Hydrochloride 6 15,653 28,630 18.9%
PRALATREXATE Pralatrexate 6 120 160 25.8%
VORINOSTAT ZOLINZA 6 239 490 19.2%
METHOXSALEN Methoxsalen 5 164 136 25.4%

View all 36 drugs →

Most Reported Drugs for Cutaneous t-cell lymphoma stage iv

#1 most reported
#2 most reported
#3 most reported